Agilent SureSelect Human All Exon V6, V6+UTR, and V6+COSMIC | GenomeWeb

Agilent SureSelect Human All Exon V6, V6+UTR, and V6+COSMIC

Jun 04, 2015

Agilent Technologies has added the SureSelect Human All Exon V6, V6+UTR, and V6+COSMIC to its line of target-enrichment products. The new products are designed to address the limitations of exome sequencing, targeting hard-to-capture and multi-mapping regions. The products also increase the sensitivity of variant calling and minimize false negative calls, Agilent said. 

The new products are compatible with the custom design capabilities of SureDesign, the sample quality control provided by the Agilent 2100 Bioanalyzer and 2200 Tapestation, the reproducible performance of the Bravo Automated Liquid Handling Platform, and the guided analysis workflows enabled by SureCall software.

More Like This

Dec 09, 2016

New England Biolabs Luna qPCR and RT-qPCR Kits

New England Biolabs has launched the Luna qPCR and RT-qPCR kits. The kits are optimized for DNA or RNA quantitation from diverse sample sources and target types, and are compatible with a wide range of instruments. The master mixes are formulated with a reference dye that universally supports real-time instruments — including high-ROX, low-ROX, and ROX-independent instruments — and a non-interfering blue visible dye to track reagents, the company said. The kits pair the company's Hot Start Taq technology with its Luna WarmStart Reverse Transcriptase, an engineered reverse transcriptase developed for robust performance and increased thermostability, for RT-qPCR applications.

Dec 08, 2016

Oxford Gene Technology SureSeq MyPanel NGS Custom FH Panel

Oxford Gene Technology has launched the SureSeq myPanel NGS Custom FH panel for the study of variants in familial hypercholesterolemia (FH). The panel includes exons for LDLR, PCSK9, APOB, LDLRAP1, APOE, LIPA, STAP1 and 14 additional single nucleotide polymorphisms associated with FH. It delivers single nucleotide variation and copy number variation detection on a single small panel and allows customization by 'mix and match' of fully-optimized genes and hotspot content, which enables researchers to selectively sequence relevant regions, the company said.

Dec 08, 2016

Invitae Breast Cancer STAT Panel Expansion

Invitae has launched an expansion of its Breast Cancer STAT panel. The expansion contains two additional breast cancer predisposition genes — ATM and CHEK2 — and a faster turnaround time with results available in as few as five days at no additional cost. The panel also includes seven well-established genes associated with a significantly increased risk of developing breast cancer: BRCA1, BRCA2, CDH1, PALB2, PTEN, STK11, and TP53. Testing is available for both blood and saliva samples.

Dec 08, 2016

Biocartis' Idylla ctKRAS Mutation Assay

Biocartis has launched is second liquid biopsy product, the the Idylla ctKRAS Mutation Assay, which it developed in partnership with Merck. The assay is designed for sensitive and rapid KRAS mutation testing and requires 1 ml of blood plasma. It enables qualitative detection of 21 KRAS mutations, with less than one minute of hands-on time and a turnaround time of approximately 130 minutes.

Dec 06, 2016

GATC Biotech InView Human Exome Explore

GATC Biotech, a Constance, Germany-based sequencing services company, has launched an exome sequencing service called InView Human Exome Explore. The service can be used for DNA from cells, blood, tissue, bacteria, yeast, fungi, and formalin-fixed paraffin-embedded tissue. Sequencing is performed under diagnostic standards and includes protocols for hard-to-capture exons. Customers also have the option of including Qiagen's Ingenuity Variant Analysis for biological interpretation. 

Dec 02, 2016

Cellecta Driver-Map Human Genome-Wide Expression Profiling Service

Cellecta has launched the Driver-Map human genome-wide expression profiling service, a targeted RNA expression method that enables quantitative expression analysis of all known 19,000 protein-coding genes in the human genome from as little as 10 pg of total RNA.

The method uses multiplexed RT-PCR directly from total RNA followed by next-generation sequencing, and employs a robust single-tube protocol with features that are particularly suitable to complex applications such as large-scale biomarker discovery and tumor microenvironment characterization. Cellecta noted that the method uses an optimized primer set that yields 1,000- to 10,000-fold dynamic range.

Dec 02, 2016

Leica Biosystems/Advanced Cell Diagnostics Aperio RNA ISH Algorithm

Leica Biosystems and Advanced Cell Diagnostics (a Bio-Techne brand) have announced the availability of the Aperio RNA ISH algorithm for use with ACD's RNAscope ISH assays.

This new offering builds on an existing collaboration between the companies to automate ACD's RNAscope assays on the Leica Biosystems BOND RX research staining platform. The new RNA ISH algorithm completes the automated RNA ISH workflow for researchers performing the RNAscope assay on the BOND RX, the companies said.

Dec 02, 2016

WaveSense nRichDx

WaveSense has launched the nRichDx system for bulk isolation of target cells and nucleic acids from liquid biopsies. The new system uses WaveSense's proprietary paramagnetic bead technology to capture circulating tumor cells and cell-free DNA or RNA in quantities sufficient for subsequent next-generation sequencing or PCR analysis. The system can capture cells and nucleic acids from an array of sample types including blood, urine, and bone marrow, and is specifically designed and optimized for high-volume, low-yield specimens, the company said.

Dec 02, 2016

CloudLIMS Lite

CloudLIMS.com has released a new version of its SaaS LIMS, CloudLIMS Lite to help biobanks and clinical, research, and testing laboratories keep track of their biospecimens from sample entry through labeling, storing, shipping and disposal. The new version is faster and more efficient product, allowing batch processing of data, inventory tracking, kit management, and centralized single-click operations coupled with an intuitive interface, the company said.

Dec 02, 2016

MyHeritage DNA Test for Genealogy

MyHeritage has launched MyHeritage DNA, a home testing kit for consumer genealogy testing. The kit consists of a cheek swab that is mailed to MyHeritage's lab for analysis. The user is then invited to view the results on the company's website.

In its initial version, the test provides two main features: detailed ethnicity reports that map the user's ethnic and geographic origins, and DNA matches for finding relatives. Additional features and capabilities are planned for the future. The initial reports currently include 25 ethnicities, but this will improve following MyHeritage's Founder Population project. In this project, the company picked more than 5,000 participants from its 85 million members, by virtue of their family trees exemplifying consistent ancestry from the same region or ethnicity for many generations. In the next few months, the project will yield a rich DNA data set of more than 100 ethnicities that will enable MyHeritage to show users their ancestral roots with far greater resolution than other services, the company said.

Dec 02, 2016

MNG Laboratories Carrier Exome

MNG Laboratories has introduced the MNG Carrier Exome, a test to determine carrier status for recessive disorders like cystic fibrosis, sickle cell anemia, and Tay-Sachs disease. The test is designed to detect a wide range of rare family or sub-population specific variants that could have an adverse effect in offspring. Whole exome sequencing is performed on both partners in order to detect shared known pathogenic and predicted disruptive variants in genes that are causative of autosomal recessive disorders. This test is intended for prospective parents who are interested in the most complete review of their genetic background to better understand their risk of having children with rare autosomal recessive disorders. It is not recommended for diagnostic purposes.

In addition to the MNG Carrier Exome, MNG Laboratories is launching a Pan-European Carrier Screen test and an Ashkenazi Jewish Carrier Screen test.

Dec 01, 2016

ArcherDx Immunoverse

ArcherDx has launched Archer Immunoverse, a suite of immune repertoire sequencing assays. The targeted panels analyze RNA using Archer's patented Anchored Multiplex PCR (AMP) chemistry for open-ended amplification from molecular barcoded adaptors and next-generation sequencing to characterize the immune repertoire. After sequencing, the Immune Repertoire pipeline is used to identify clonotypes. The workflow requires less than 3.5 hours of hands-on time and between 25 nanograms and 2 micrograms of input RNA from peripheral blood mononuclear cells, formalin-fixed paraffin-embedded tissue, or fresh frozen tissue.

Nov 30, 2016

Phenomenex Clarity LC Columns for Synthetic Oligo Analysis

Phenomenex has launched two new products for characterization and purification of synthetic oligonucleotides, the Clarity Oligo-XT C18 column and the Clarity Oligo-SAX column.

The products will be offered as part of the firm's Clarity BioSolutions portfolio of columns for chromatographic analysis.

The Oligo-XT C18 column is intended for high-efficiency reversed-phase liquid chromatography analysis and purification. Featuring new and robust core-shell media, it offers the separation power to resolve closely related synthetic oligos and the sensitivity to improve quantitation by mass spectrometry. The columns are available in directly scalable 1.7-micrometer, 2.5-micrometer, and 5-micrometer particle sizes. 

The Oligo-SAX is a high-resolution strong anion exchanger for characterization, featuring new rugged non-porous particles for improved column lifetimes. It is engineered for performance at high pH and temperatures up to 85° C. It comes in a 5-micrometer particle size for analytical characterization.

Nov 23, 2016

NextGene 2.4.2

SoftGenetics has released NextGene 2.4.2. The release features a new batch CNV tool for screening copy number variants, a unique molecular identifier tool for removing duplicate reads from most commercially available chemistries, and templates for analyzing data from the NEBNext Direct Cancer HotSpot panel and the Direct BRCA panel. The software also offers in-read phasing capabilities, tools for sharing reference tracks with various genome builds, and integrated preloaded references with track manager. The software is integrated with SoftGenetics' Geneticist Assistant NGS Workbench.

Nov 22, 2016

CosmosID's Metagenomics Plugin for Qiagen's Products

Qiagen and CosmosID have launched a metagenomics analysis plugin for the Qiagen Microbial Genomics Pro suite and the CLC Genomics Workbench. The CosmosID plugin offers support for shotgun metagenomics and microbiome profiling for application in the fields of infectious disease, food safety, animal health, agriculture, and environmental analysis. According to the developers, the plugin will enable customers of Qiagen's informatics products profile microbial communities quickly and accurately with strain level resolution. 

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.